Register      Login
New South Wales Public Health Bulletin New South Wales Public Health Bulletin Society
Supporting public health practice in New South Wales
RESEARCH ARTICLE

Diagnosis, treatment and prevention of tuberculosis in children

Philip Britton A , Carlos M. Perez-Velez B C and Ben J. Marais A C D
+ Author Affiliations
- Author Affiliations

A The Children’s Hospital at Westmead

B Grupo Tuberculosis Valle-Colorado and Clínica León XIII, IPS Universidad de Antioquia, Colombia

C Sydney Emerging Infectious Diseases and Biosecurity Institute, The University of Sydney

D Corresponding author. Email: ben.marais@health.nsw.gov.au

NSW Public Health Bulletin 24(1) 15-21 https://doi.org/10.1071/NB12100
Published: 15 July 2013

Abstract

In Australia, tuberculosis notification rates have plateaued at a low level and disease is highly concentrated in immigrant communities where children may be affected. Many clinicians regard tuberculosis as an adult disease, hence it is rarely considered in the differential diagnosis of sick children. This paper provides a brief overview of the natural history of the disease in children to demonstrate the importance of taking a careful tuberculosis exposure history. It also provides guidance regarding the diagnosis, treatment and prevention of tuberculosis in children. The management of paediatric cases is not difficult if important differences with adult disease are carefully considered; these differences are discussed in detail.


References

[1]  Marais BJ, Gupta A, Starke JR, El Sony A. Tuberculosis in women and children. Lancet 2010; 375 2057–9.
Tuberculosis in women and children.Crossref | GoogleScholarGoogle Scholar | 20488522PubMed |

[2]  World Health Organization. Global tuberculosis report 2012. Geneva: World Health Organization; 2012.

[3]  Raviglione M, Marais B, Floyd K, Lönnwroth K, Getahun H, Migliori GB, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012; 379 1902–13.
Scaling up interventions to achieve global tuberculosis control: progress and new developments.Crossref | GoogleScholarGoogle Scholar | 22608339PubMed |

[4]  Barry C, Waring J, Stapledon R, Konstantinos A, National Tuberculosis Advisory Committee, for the Communicable Diseases Network Australia Tuberculosis notifications in Australia, 2008 and 2009. Commun Dis Intell 2012; 36 82–94.

[5]  Merritt TD, Sintchenko V, Jelfs P, Worthing M, Robinson B, Durrheim DN, et al. An outbreak of pulmonary tuberculosis in young Australians. Med J Aust 2007; 186 240–2.
| 17391086PubMed |

[6]  Roberts-Witteveen AR, Christensen A, McAnulty JM. EpiReview: Tuberculosis in NSW, 2008. N S W Public Health Bull 2010; 21 174–82.
EpiReview: Tuberculosis in NSW, 2008.Crossref | GoogleScholarGoogle Scholar | 20883656PubMed |

[7]  Menzies HJ, Winston CA, Holtz TH, Cain KP, Mac Kenzie WR. Epidemiology of tuberculosis among US- and foreign-born children and adolescents in the United States, 1994-2007. Am J Public Health 2010; 100 1724–9.
Epidemiology of tuberculosis among US- and foreign-born children and adolescents in the United States, 1994-2007.Crossref | GoogleScholarGoogle Scholar | 20634457PubMed |

[8]  Sandgren A, Hollo V, Quinten C, Manissero D. Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009. Euro Surveill 2011; 16 19825
| 21457686PubMed |

[9]  Tebruegge M, Ritz N, Connell T, Curtis N. A 2-year old girl with fever, cough, and tachypnoea. BMJ 2009; 338 b1210
A 2-year old girl with fever, cough, and tachypnoea.Crossref | GoogleScholarGoogle Scholar | 19515707PubMed |

[10]  Patradoon-Ho PS, Ambler RW. Universal post-arrival screening for child refugees in Australia: isn't it time? J Paediatr Child Health 2012; 48 99–102.
Universal post-arrival screening for child refugees in Australia: isn't it time?Crossref | GoogleScholarGoogle Scholar | 22320270PubMed |

[11]  Ritz N, Connell TG, Tebruegge M, Johnstone BR, Curtis N. Tuberculous dactylitis—an easily missed diagnosis. Eur J Clin Microbiol Infect Dis 2011; 30 1303–10.
Tuberculous dactylitis—an easily missed diagnosis.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3MbgtFSrsQ%3D%3D&md5=4790c50794213b5c5a849e1c0a554279CAS | 21491177PubMed |

[12]  Thoo CH, Graf N, Hogan P. Erythema induratum in a Kenyan child. Australas J Dermatol 2008; 49 156–8.
Erythema induratum in a Kenyan child.Crossref | GoogleScholarGoogle Scholar | 18638224PubMed |

[13]  Blyth C, Waring J, Burgner D. Inconspicuous consumption: disseminated tuberculosis following untreated latent infection. J Paediatr Child Health 2004; 40 227–9.
Inconspicuous consumption: disseminated tuberculosis following untreated latent infection.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2c7itVaitg%3D%3D&md5=1adfe2e9057721d59e729b1a862239bfCAS | 15009555PubMed |

[14]  Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med 2012; 367 348–61.
Tuberculosis in children.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC38XhtFegsrvI&md5=b44e0d8fe08d8cf5f893e2cbaa3e4ccfCAS | 22830465PubMed |

[15]  Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of the pre-chemotherapy literature. Int J Tuberc Lung Dis 2004; 8 392–402.
| 1:STN:280:DC%2BD2c3ktlamsw%3D%3D&md5=b4817b583dcd61f20c892bd32bdba0d3CAS | 15141729PubMed |

[16]  Donald PR, Marais BJ, Barry CE. Age and the epidemiology and pathogenesis of tuberculosis. Lancet 2010; 375 1852–4.
Age and the epidemiology and pathogenesis of tuberculosis.Crossref | GoogleScholarGoogle Scholar | 20488519PubMed |

[17]  Curtis AB, Ridzon R, Vogel R, McDonough S, Hargreaves J, Ferry J, et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med 1999; 341 1491–5.
Extensive transmission of Mycobacterium tuberculosis from a child.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3c%2FgslCqtQ%3D%3D&md5=ffe9e8b5a93639f9bacbcbd6e268718fCAS | 10559449PubMed |

[18]  Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Enarson DA, Beyers N. Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings. Pediatr Infect Dis J 2006; 25 237–40.
Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings.Crossref | GoogleScholarGoogle Scholar | 16511386PubMed |

[19]  World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization; 2006.

[20]  Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006; 118 e1350–9.
A refined symptom-based approach to diagnose pulmonary tuberculosis in children.Crossref | GoogleScholarGoogle Scholar | 17079536PubMed |

[21]  Marais BJ, Gie RP, Schaaf HS, Starke JR, Hesseling AC, Donald PR, et al. A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 2004; 34 886–94.
A proposed radiological classification of childhood intra-thoracic tuberculosis.Crossref | GoogleScholarGoogle Scholar | 15300340PubMed |

[22]  Gie RP. Diagnostic atlas of intrathoracic tuberculosis in children: a guide for low-income countries. Paris: International Union Against Tuberculosis and Lung Disease; 2003. Available at: http://www.theunion.org/index.php/en/resources/technical-publications/item/110-diagnostic-atlas-of-intrathoracic-tuberculosis-in-children (Cited 25 July 2012).

[23]  Andronikou S, van Hoenacker FM, de Backer AI. Advances in imaging chest tuberculosis: blurring of differences between children and adults. Clin Chest Med 2009; 30 717–44.
Advances in imaging chest tuberculosis: blurring of differences between children and adults.Crossref | GoogleScholarGoogle Scholar | 19925963PubMed |

[24]  Pienaar M, Andronikou S, van Toorn R. MRI to demonstrate diagnostic features and complications of TBM not seen with CT. Childs Nerv Syst 2009; 25 941–7.
MRI to demonstrate diagnostic features and complications of TBM not seen with CT.Crossref | GoogleScholarGoogle Scholar | 19107489PubMed |

[25]  National Tuberculosis Advisory Committee Position statement on interferon-gamma release assays in the detection of latent tuberculosis infection. Commun Dis Intell 2012; 36 125–31.

[26]  Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011; 11 819–24.
Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study.Crossref | GoogleScholarGoogle Scholar | 21764384PubMed |

[27]  Rachow A, Clowes P, Saathoff E, Mtafya B, Michael E, Ntinginya EN, et al. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis 2012; 54 1388–96.
Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study.Crossref | GoogleScholarGoogle Scholar | 22474220PubMed |

[28]  Nicol MP, Zar HJ. New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev 2011; 12 16–21.
New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects.Crossref | GoogleScholarGoogle Scholar | 21172670PubMed |

[29]  Wright CA, Warren RW, Marais BJ. Fine needle aspiration biopsy: an undervalued diagnostic modality in paediatric mycobacterial disease. Int J Tuberc Lung Dis 2009; 13 1467–75.
| 1:STN:280:DC%2BD1MjmslOqtg%3D%3D&md5=720833adbc2575a931ab72943d222cedCAS | 19919763PubMed |

[30]  Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK, Prasad K, et al. Tuberculous meningitis: defining a uniform case definition for use in clinical research. Lancet Infect Dis 2010; 10 803–12.
Tuberculous meningitis: defining a uniform case definition for use in clinical research.Crossref | GoogleScholarGoogle Scholar | 20822958PubMed |

[31]  Donald PR. The chemotherapy of tuberculous meningitis in children and adults. Tuberculosis (Edinb) 2010; 90 375–92.
The chemotherapy of tuberculous meningitis in children and adults.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhtl2it7zL&md5=41a5ada479598206e0de5f6e16790d83CAS | 20810322PubMed |

[32]  Seddon JA, Furin JJ, Gale M, Del Castillo Barrientos H, Hurtado RM, Amanullah F, et al. Caring for children with drug-resistant tuberculosis: practice-based recommendations. Am J Respir Crit Care Med 2012; 186 953–64.
Caring for children with drug-resistant tuberculosis: practice-based recommendations.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXpsVehsg%3D%3D&md5=924cb14d459b0673f075e715d2ece4eeCAS | 22983960PubMed |

[33]  Marais BJ, Rabie H, Cotton MF. TB and HIV in children – advances in prevention and management. Paediatr Respir Rev 2011; 12 39–45.
TB and HIV in children – advances in prevention and management.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3M%2FlslWrtw%3D%3D&md5=76f55bf15807d0a16df9db512114db38CAS | 21172674PubMed |

[34]  Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367 1173–80.
Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.Crossref | GoogleScholarGoogle Scholar | 16616560PubMed |

[35]  Spyridis NP, Spyridis PG, Gelesme A, Sypsa V, Valianatou M, Metsou F, et al. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis 2007; 45 715–22.
The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXhtFahtrrP&md5=f7b29b89ee15e45866f9108042a54541CAS | 17712755PubMed |

[36]  Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 365 2155–66.
Three months of rifapentine and isoniazid for latent tuberculosis infection.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3MXhs1WqtrnP&md5=d432909e6f761113cc57bf392df04820CAS | 22150035PubMed |

[37]  Detjen AK, Macé C, Perrin C, Graham SM, Grzemska M. Adoption of revised dosage recommendations for childhood tuberculosis in countries with different childhood tuberculosis burdens. Public Health Action 2012; 2 126–32.
Adoption of revised dosage recommendations for childhood tuberculosis in countries with different childhood tuberculosis burdens.Crossref | GoogleScholarGoogle Scholar |

[38]  Antibiotic Expert Group. Therapeutic guidelines: antibiotic. Version 14. Melbourne: Therapeutic Guidelines Limited; 2010.

[39]  Marais BJ, Graham SM, Maeurer M, Zumla A. Progress, challenges and concepts from childhood tuberculosis. Lancet (in press)